Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer

Selective serotonin reuptake inhibitors (SSRIs) are a widely prescribed class of antidepressants. Laboratory and epidemiologic evidence suggests that a prolactin-mediated mechanism secondary to increased serotonin levels at neuronal synapses could lead to a potentially carcinogenic effect of SSRIs....

Descripción completa

Detalles Bibliográficos
Autores principales: Ashbury, Janet E., Lévesque, Linda E., Beck, Patricia A., Aronson, Kristan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514533/
https://www.ncbi.nlm.nih.gov/pubmed/23227451
http://dx.doi.org/10.3389/fonc.2012.00177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514533/
https://www.ncbi.nlm.nih.gov/pubmed/23227451
http://dx.doi.org/10.3389/fonc.2012.00177

Ejemplares similares